WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a 1-for-50 reverse stock split of its common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback